Alligator Bioscience
0.20 SEK
-1.81 %
Less than 1K followers
ATORX
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Alligator Bioscience
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.4 | 41.8 | 57.8 | 0.5 | 0.1 | 0.5 | ||
| EBITDA | -59.9 | -18.3 | -180.4 | -42.6 | -10.4 | -17.0 | ||
| EBIT | -62.0 | -60.1 | -229.1 | -43.7 | -22.3 | -17.3 | -22.6 | -105.8 |
| EBIT-% | -4,338.5 % | -143.8 % | -396.6 % | -3,695.1 % | -45,100.0 % | -20,588.7 % | ||
| Profit before taxes | -66.5 | -55.4 | -233.9 | -8.4 | -1.7 | -12.3 | -29.1 | -51.4 |
| Net income | -66.5 | -55.4 | -233.9 | -8.4 | -1.7 | -12.3 | -29.1 | -51.4 |